tirzepatide available Flex-Dose 1 mL Injectable 10 mg/mL Tirzepatide (GLP-1/GIP) - 15mg -

Many patients with gastritis already use proton-pump inhibitors (PPIs) or H2 blockers, which should continue during GLP-1 therapy

By mimicking incretin hormones, it slows gastric emptying, decreases food intake, and improves insulin resistance, creating a potent synergy for weight loss benefits and to improve metabolic health

J Manag Care Spec Pharm 2018;24(9-a Suppl.):S42S52 [DOI] [PMC free article] [PubMed] [Google Scholar] 40.Zweck E, Roden M

At 48 weeks, of people given 8 mg, 100% lost 5%+, 91% lost 10%+, and 75% lost 15%+

"Effect of spices on perceived saltiness." J Sci Food Agric

What It Is Tirzepatide is a dual GIP/GLP-1 receptor agonist